A MRD‐GUIDED APPROACH FOR THE COMBINATION OF IBRUTINIB TO VENETOCLAX IN RELAPSED/REFRACTORY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (IMPROVE STUDY)

Saved in:
Bibliographic Details
Published in:Hematological oncology 2017-06, Vol.35 (S2), p.426-427
Main Authors: Ghia, P., Scarfò, L., Coscia, M., Sancetta, R., Ferrario, A., Tedeschi, A., Farina, L., Laurenti, L., Orlandi, E., Reda, G., Motta, M., Carlo Stella, C., Massaia, M., Quaresmini, G., Rossini, F., Ladetto, M., Gaidano, G., Rossi, V., Montillo, M.
Format: Article
Language:English
Subjects:
Chronic lymphocytic leukemia
Leukemia
Lymphatic leukemia
Patients
Targeted cancer therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.2440_11